Using technology to help reduce alcohol use and improve HIV treatment in Florida
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
This study is looking for people living with HIV who drink alcohol to understand how drinking affects their health and treatment, and it will involve surveys and a small group using a wrist device to track their drinking for a month.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10897096 on NIH RePORTER |
What this research studies
This research focuses on individuals living with HIV who also consume alcohol, as alcohol use can negatively impact their health outcomes. The study aims to enroll 1,200 participants from the Florida Cohort, particularly targeting heavy drinkers and diverse populations. Participants will complete surveys to identify factors affecting their adherence to HIV treatment and viral suppression. Additionally, a smaller group will use a wrist biosensor to monitor alcohol consumption for one month, providing valuable data to inform interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also engage in alcohol consumption, particularly heavy drinkers and those from diverse sexual and ethnic backgrounds.
Not a fit: Patients who do not consume alcohol or those who are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV treatment adherence and better health outcomes for individuals who consume alcohol.
How similar studies have performed: Previous research has shown that technology-based interventions can effectively improve health outcomes in similar populations, suggesting a promising approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Cook, Robert L — University of Florida
- Study coordinator: Cook, Robert L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.